Wednesday, July 8, 2026

pharma · Acute Pain · Pharmacokinetics · ENSC

Ensysce Biosciences

Ensysce Biosciences patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

La Jolla, USA HQ
2008 Founded
13 Employees
Public company Type
ENSC · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2008
Employees
13
Programs
6
Drugs
2
Patents
2
Intelligence · Patents

Ensysce Biosciences patents

2 pharmaceutical patents indexed for Ensysce Biosciences. 0 expire within 24 months.

Ensysce Biosciences has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12384744

    Enzyme-cleavable methadone prodrugs and methods of use thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8772258

    Single walled carbon nanotube/sirna complexes and methods related thereto

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Ensysce Biosciences have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Ensysce Biosciences patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.